Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Other Working Capital Changes (2016 - 2025)

GeoVax Labs (GOVX) has disclosed Other Working Capital Changes for 16 consecutive years, with $275555.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Working Capital Changes rose 116.39% to $275555.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $15937.0, a 101.43% increase, with the full-year FY2024 number at -$1.1 million, down 13.21% from a year prior.
  • Other Working Capital Changes was $275555.0 for Q3 2025 at GeoVax Labs, up from -$259618.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $939487.0 in Q2 2022 to a low of -$1.7 million in Q3 2024.
  • A 5-year average of $5424.1 and a median of -$22829.5 in 2021 define the central range for Other Working Capital Changes.
  • Peak YoY movement for Other Working Capital Changes: soared 2734.57% in 2022, then plummeted 16714.26% in 2024.
  • GeoVax Labs' Other Working Capital Changes stood at $106979.0 in 2021, then skyrocketed by 752.26% to $911737.0 in 2022, then plummeted by 101.1% to -$10000.0 in 2023, then tumbled by 16714.26% to -$1.7 million in 2024, then surged by 116.39% to $275555.0 in 2025.
  • Per Business Quant, the three most recent readings for GOVX's Other Working Capital Changes are $275555.0 (Q3 2025), -$259618.0 (Q2 2025), and -$1.7 million (Q3 2024).